Your browser doesn't support javascript.
loading
In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
Sawant-Mane, S; Clark, M B; Koski, C L.
Affiliation
  • Sawant-Mane S; Department of Neurology, University of Maryland, Baltimore 21201.
Ann Neurol ; 29(4): 397-404, 1991 Apr.
Article in En | MEDLINE | ID: mdl-1718212
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polyradiculoneuropathy / Complement C7 / Complement Membrane Attack Complex / Demyelinating Diseases / Nerve Fibers, Myelinated Limits: Animals / Humans Language: En Journal: Ann Neurol Year: 1991 Document type: Article Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polyradiculoneuropathy / Complement C7 / Complement Membrane Attack Complex / Demyelinating Diseases / Nerve Fibers, Myelinated Limits: Animals / Humans Language: En Journal: Ann Neurol Year: 1991 Document type: Article Country of publication: Estados Unidos